News

Find News

Filter articles

Applied Filters

Showing 841 to 850 of 911 results

Aurobindo to acquire Actavis’s European generic units

EU, India20-01-2014Mergers & acquisitions

Aurobindo’s European subsidiary is set to acquire Actavis’s commercial generic operations in seven Western European markets in a deal worth about €30 million ($40 million).

South African PR efforts spark drug controversy

South Africa17-01-2014

South African drug companies have been accused by advocacy organisations of planning a "deceptive" campaign to delay new laws which could see the introduction of more generic medicines.

Court says Teva not infringing OxyContin patents

US15-01-2014

A US judge has said Teva Pharmaceuticals did not infringe patents belonging to a rival company after seeking approval to market a generic version of the drug.

EIP hires Teva litigator

UK07-01-2014

EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.

Pfizer allows Teva’s generic Viagra

US19-12-2013Legal developments

Viagra-maker Pfizer Ltd and Teva Pharmaceutical Industries have agreed to settle patent litigation related to Teva’s generic version of Viagra (sildenafil citrate) tablets.

FDA approves first generic versions of Lilly’s $5bn Cymbalta

US16-12-2013

The US Food and Drug Administration (FDA) has approved the first generic versions of antidepressant drug Cymbalta (duloxetine hydrochloride), after Eli Lilly’s primary patent covering the product expired on December 11.

Australian High Court says medical treatment methods are patentable

Australia12-12-2013

The High Court in Australia has said for the first time that a method of medical treatment for the human body can be a patentable invention.

Politicians plead with Obama over TPP drug rules

US11-12-2013

Six US congressman have implored President Barack Obama to ensure that the Trans Pacific Partnership does not include measures that undermine access to affordable healthcare.

C5 Forum on Biosimilars: the importance of regulation

05-12-2013

At the 3rd C5 Forum on Biosimilars in London on Wednesday, a panel of lawyers and regulatory experts discussed the lie of the land for biosimilars.

Novartis takes on Roxane Laboratories over drug application

US03-12-2013

Novartis Pharmaceuticals has filed a lawsuit against US drug manufacturer Roxane Laboratories disputing an application for a schizophrenia drug.

Showing 841 to 850 of 911 results

LSIPR